What is Integra LifeSciences's revenue?

Integra LifeSciences (IART) generated $1.6B in revenue over the trailing twelve months, up 1.2% year over year.

Is Integra LifeSciences profitable?

Integra LifeSciences is not currently profitable: it reported a net loss of $495.8M over the trailing twelve months, a -30.1% net margin.

What are Integra LifeSciences's profit margins?

Gross margin is 51.9% and operating margin is -29.8%, with a -30.1% net margin.

What is Integra LifeSciences's earnings per share?

Integra LifeSciences's diluted EPS over the trailing twelve months is $-6.46.

Where does Integra LifeSciences's income statement data come from?

Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Integra LifeSciences IART Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$391.92M+2.4%	$434.93M-1.7%	$402.06M+5.6%	$415.61M-0.6%	$382.65M+3.7%
Total cost of revenue	$174.94M-7.1%	$214.06M+10.6%	$195.07M+8.0%	$206.27M+7.3%	$188.22M+16.2%
Gross profit	$216.98M+11.6%	$220.87M-11.3%	$206.99M+3.4%	$209.33M-7.3%	$194.43M-6.0%
Gross margin	55.4%+4.6pp	50.8%-5.5pp	51.5%-1.1pp	50.4%-3.7pp	50.8%-5.3pp
Research and development	$23.5M-5.0%	$24.79M-20.6%	$22.46M-18.1%	$27M-9.3%	$24.73M-8.3%
Selling, general and administrative	$178.24M-1.8%	$169.27M-5.2%	$169.05M-4.6%	$179.89M-8.0%	$181.5M+9.5%
Total costs & expenses	$380.45M-4.4%	$411.89M+1.2%	$390.3M+0.3%	$928.28M+120%	$398.15M+9.1%
Operating income	$11.47M+174%	$0-100%	$11.76M+244%	-$512.67M-16,826%	-$15.5M-491%
Operating margin	2.9%+7.0pp	0%-8.0pp	2.9%+5.1pp	-123.4%-123pp	-4%-5.1pp
Interest expense	$22.47M+19.4%	$23.67M+24.7%	$22.73M+17.3%	$21.04M+12.8%	$18.82M+38.1%
Other income (expense), net	$4.48M+3,211%	——	-$842K-140%	-$1.95M-235%	-$144K+76.4%
Income before income taxes	-$2.41M+92.0%	$0—	-$6.82M+66.5%	-$530.95M-3,397%	-$30.04M-474%
Income tax expense	$2.21M+147%	——	-$1.42M+85.3%	-$46.88M-1,584%	-$4.74M-143%
Net income	-$4.62M+81.7%	-$1.7M—	-$5.4M+49.5%	-$484.07M-3,803%	-$25.29M-671%
Net margin	-1.2%+5.4pp	-0.4%—	-1.3%+1.5pp	-116.5%-114pp	-6.6%-5.7pp
Diluted earnings per share	-$0.06+81.8%	-$0.02—	-$0.07+50.0%	-$6.31-3,844%	-$0.33-725%
EBITDA	$53.68M+111%	$42.2M-45.1%	$54.01M+71.1%	-$471.23M-1,358%	$25.4M-43.1%
EBITDA margin	13.7%+7.1pp	9.7%-7.7pp	13.4%+5.1pp	-113.4%-122pp	6.6%-5.5pp
EBIT	$11.47M+174%	$0-100%	$11.76M+244%	-$512.67M-16,826%	-$15.5M-491%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Integra LifeSciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's revenue?: Integra LifeSciences (IART) generated $1.6B in revenue over the trailing twelve months, up 1.2% year over year.
Is Integra LifeSciences profitable?: Integra LifeSciences is not currently profitable: it reported a net loss of $495.8M over the trailing twelve months, a -30.1% net margin.
What are Integra LifeSciences's profit margins?: Gross margin is 51.9% and operating margin is -29.8%, with a -30.1% net margin.
What is Integra LifeSciences's earnings per share?: Integra LifeSciences's diluted EPS over the trailing twelve months is $-6.46.
Where does Integra LifeSciences's income statement data come from?: Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.